Some #Cytopath #Histopath correlation. The 3 components of a Wilms tumour: Blastemal, Epithelial and Blastemal #PediPath 🔬

Teaching "nuclear pleomorphism" to the incoming pathology interns next month - Hepatocellular Carcinoma. (FNA)

Normalize calling the pathology laboratory a patient-care area. #HealingBeginsWithADiagnosis

CC390. FNA of a malar nodule (<1 cm) in an old man. Two more images below #cytopath @kriyer68 @kis_lorand @DrMarkOng @edusqo @MAHoureih @AnupamaArya12 @premcharles

What is your diagnosis in a sentinel axillary LN

trainees: come sharpen your #surgpath skills with us! sadly, good surgpath fellowships are hard to find, so don’t miss out! ⬇️openings for 2028-2029 now avail! app.smartsheet.com/b/form/e5…

Parotid Mass - dispersed cells with macronucleoli, cytoplasmic pigment and an intranuclear inclusion. "Metastatic Melanoma" until proven otherwise. IHCs will be optional and often not needed in the presence of a known history. (FNA)

Always the best #Cytopath images on X!

One classic pic. Your diagnosis? Answer ✅ : youtube.com/watch?v=iyr3D0QQ… More images: kikoxp.com/posts/8614. #pathology #pathologists #pathTwitter #dermpath #dermatology #dermatologia #dermtwitter

In my 1977 study of 128 open lung biopsies from patients with sarcoidosis, granulomatous vasculitis was observed in 69% of the biopsy specimens (PMID: 576782). In a subsequent study published in 1999 the authors found granulomatous vasculitis in 100% of 40 patients with sarcoidosis studied at autopsy. (PMID:1427751 ). Despite the high incidence of granulomatous vasculitis in the lungs of patients with sarcoidosis demonstrated by surgical lung biopsies and autopsy, this lesion is rarely seen in transbronchial lung biopsies. Granulomatous vasculitis can occasionally be seen in conditions other than sarcoidosis as shown in the accompanying images.

Happy to share our new #PediPath contribution on diagnosing #Ovotestis #Uropath #DSD @clamsalgado @UMiamiPathology link.springer.com/article/10…

What stain is this? Hmmmm…Oil? Red? O! #PathX #Cytopath

New paper out! 47% of the world cannot access basic diagnostics. Pathologists are the missing link. Our @umichmedicine @UMichPath Global Pathology Summit brought experts from 8 countries together to map out how to actually address pathology disparities in LMICs. National ownership, smarter use of digital tools, and retention strategies that treat pathologists like the specialists they are. Full paper linked here: considerations.bmj.com/conte… @RoubaAliFehmi @BalisUlysses @AkbarWaljee @jckolars @robinpetroze

Skin Adnexal tumor quiz. View these 12 unknown digital slides via @ pathpresenter: pathpresenter.net/#/public/p…. Quiz yourself, then check answers here: youtube.com/watch?v=rcVWaqz8… #dermpath #dermatology #dermatologia #dermtwitter #pathologists #pathology #pathTwitter

.#Pathology education has historically depended on geography, institutional privilege, cost, and access. We wanted to challenge that. What started during the chaos of COVID became something much bigger. Our new paper on @PathElective shows that a free, virtual, globally accessible pathology education platform reached learners across nearly every region of the world, across diverse backgrounds, training levels, identities, and lived experiences. More importantly, the data tell a deeper story. Nearly a quarter of respondents reported difficulty accessing reliable internet. Less than half grew up in English-speaking households. Many were balancing jobs while training. And yet, 76% felt PathElective was more accessible than traditional educational resources, while 72% felt it filled an unmet educational need. That matters because education should not belong only to those born into the “right” systems. For years, pathology has talked about visibility, access, pipeline development, and global engagement. This project was an attempt to actually build something instead of just talking about it. Proud of this work and proud of the incredible collaborators who helped create PathElective. Proud that a pathology platform built with generosity and community at its core could reach people from around the world. And honestly, I think this is just the beginning of what democratized medical education can become. @AcadPathol @apcprods @UMichPath #Pathology #MedEd #MedicalEducation #DigitalPathology #PathTwitter #FOAMed #GlobalHealth #Hematopathology #PathElective #AcademicMedicine #MedicalStudents #Residency #MedicalEducationResearch clinicalkey.com/#!/content/p…

The human body has lessons to teach all of us in medicine. As a hematopathologist, I’m especially partial to the bone marrow. During my 2026 commencement keynote at Loyola University Chicago Stritch School of Medicine, I shared how the marrow models attentiveness, responsiveness, connectedness, adaptability, and resilience in ways that medicine should never forget. Here’s a snapshot of a few of those lessons. @LoyolaStritch @UMichPath @umichmedicine @UMichRISE @UMichMedSchool

‘Without wonder, medicine becomes transactional.’ This rings so true. I’ve seen this wonder disappear in the stress of a challenging profession, and had days where I’ve lost it myself. Please take a moment out of your day to watch and remember that sense of wonder. #MedX

A small subset of insulinomas are aggressive and as shown by our colleagues in the Netherlands, they express ARX instead of PDX1. @UPMC and other centers we often test these as part of preoperative care as they are $10 stains. Cheap but important!

TGIF: Teen with history of travel to 🇩🇴 a week prior to conjunctiva lesions (0.5 cm) Seen this some 25 years ago. @ParasiteGal @leon_metlay @DrJuhlin @SabBergeron @Histopatolomon @yro854 #pathtwitter #PathBugs #CrittersonTwitter #ENTPath #TGIF

19. There is a concept PGY1s should know about in lung cancer: "spread through air spaces" or "STAS". This is tumor within alveolar lumens (green circles) beyond the edge of the main mass (red line). Associated with micropapillary growth, lymph node mets & poor prognosis

Congratulations to Dr. Aatur Singhi (@PancPathologist) for recognition he has received for his work on BiliSeq, a molecular test used in the detection of bile duct cancer. Follow the link for Dr. Singhi's recent interview with @Medscape about this work. medscape.com/viewarticle/nex…